Core Viewpoint - Jamieson Wellness Inc. has received approval from the Toronto Stock Exchange to renew its normal course issuer bid, allowing the company to repurchase up to 3,502,925 common shares, representing approximately 10% of its public float as of January 20, 2025 [1] Group 1: Normal Course Issuer Bid (NCIB) - The NCIB will commence on February 3, 2025, and will expire on February 2, 2026, or when the maximum number of shares is acquired [1] - As of January 20, 2025, there were 41,950,837 common shares issued and outstanding [1] - The average daily trading volume for the six months ended December 31, 2024, was 46,979 common shares, allowing Jamieson to repurchase up to 25% of this volume daily, equating to 11,744 common shares [2] Group 2: Share Repurchase Mechanism - Purchases will be conducted through open market transactions on the TSX and alternative trading systems in Canada, with the repurchase price being the market price at the time of acquisition [3] - All repurchased shares under the NCIB will be cancelled [3] Group 3: Automatic Share Purchase Plan (ASPP) - The company has established an automatic share purchase plan with a designated broker to facilitate share purchases during predetermined blackout periods, effective February 3, 2025 [4] Group 4: Company Overview - Jamieson Wellness, established in 1922, is Canada's leading brand in vitamins, minerals, and supplements, with its products available in over 50 countries [5] - The company also offers a variety of innovative VMS products and sports nutrition products under various brands, including Progressive, Smart Solutions, Iron Vegan, and Precision [5]
Jamieson Wellness Inc. Announces Normal Course Issuer Bid